» Articles » PMID: 11857419

Familial Aggregation of Urothelial Cell Carcinoma

Overview
Journal Int J Cancer
Specialty Oncology
Date 2002 Feb 22
PMID 11857419
Citations 42
Authors
Affiliations
Soon will be listed here.
Abstract

Urothelial cell carcinoma (UCC) is not considered to be a familial disease. Familial clustering of UCC was described in several case reports, however, some with an extremely early age at onset suggesting a genetic component. Epidemiological studies yielded inconsistent evidence of familial UCC, possibly because of low power and the inability to adjust for strong confounding. In our study the existence of a familial subtype of UCC was evaluated, as well as familial clustering of UCC with other types of cancer. A population-based family case-control study was performed including patients newly diagnosed with UCC of the bladder, ureter, renal pelvis or urethra, between January 1995 and December 1997, in the southeastern part of the Netherlands. Information on the patients' first-degree relatives was collected by postal questionnaire and subsequent telephone calls. The patients' partners filled out a similar questionnaire on their relatives. All reported occurrences of UCC were verified using medical records. Disease occurrence among case-relatives and control-relatives was compared to obtain the familial risk. Random effect proportional hazards regression analyses were used to calculate this familial risk while adjusting for age, gender and smoking behavior. In 95 families of the 1,193 patients and in 36 families of the 853 partners at least 1 relative was diagnosed with UCC. This yielded an adjusted hazard ratio (HR) of 1.8 (95% CI: 1.3-2.7). An increased risk was also found for cancer of the hematolymphopoietic system (hazard ration = 1.9, 95% CI: 1.2-3.1) among case-relatives. These results indicate that UCC has a familial component with an almost 2-fold increased risk among first-degree relatives of patients with UCC, which cannot be explained by smoking. Future segregation analyses may indicate whether this clustering can be attributed to genetic susceptibility.

Citing Articles

A Plasmacytoid Variant of Urothelial Carcinoma: A Rare Entity.

Yasmin A, Waheed M, Jamil M, Imran M, Majeed M Cureus. 2024; 16(8):e67436.

PMID: 39310501 PMC: 11415524. DOI: 10.7759/cureus.67436.


The Significant Associations between Epigenetic Clocks and Bladder Cancer Risks.

Deng Y, Tsai C, Chang W, Xu Y, Huang M, Bau D Cancers (Basel). 2024; 16(13).

PMID: 39001419 PMC: 11240392. DOI: 10.3390/cancers16132357.


Familial Risk and Interaction With Smoking and Alcohol Consumption in Bladder Cancer: A Population-Based Cohort Study.

Kim H, Kim K, Lee S, Swan H, Kazmi S, Kim Y World J Oncol. 2023; 14(5):382-391.

PMID: 37869241 PMC: 10588503. DOI: 10.14740/wjon1639.


Variability, Expression, and Methylation of and Genes in Bladder Cancer Pathophysiology.

Grebowski R, Saluk J, Bijak M, Szemraj J, Wigner P Int J Mol Sci. 2023; 24(7).

PMID: 37047238 PMC: 10093978. DOI: 10.3390/ijms24076266.


Plasmacytoid Variant Urothelial Cell Carcinoma: A Case of a Histological Variant of Urinary Bladder Cancer With Aggressive Behavior.

Alshahwan M, Bin Dukhi M, Alotaibi S, Aldarrab R, Alhefdhi N, Al Oudah N Cureus. 2023; 15(3):e36278.

PMID: 36937121 PMC: 10022250. DOI: 10.7759/cureus.36278.